Latest Articles

Publication Date
All News Scientific
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer - BioSpace

Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer BioSpace

Published: Feb. 4, 2026, 4:47 a.m.
Read Full Article
Gsk - Quebec To Reimburse Jemperli Plus Chemotherapy Via Ramq For Primary Advanced/First Recurrent Endometrial Cancer - TradingView

Gsk - Quebec To Reimburse Jemperli Plus Chemotherapy Via Ramq For Primary Advanced/First Recurrent Endometrial Cancer TradingView

Published: Feb. 3, 2026, 1:11 p.m.
Read Full Article
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer - Newswire Canada

Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer Newswire …

Published: Feb. 3, 2026, 1 p.m.
Read Full Article
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer - Yahoo Finance Singapore

Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer Yahoo …

Published: Feb. 3, 2026, 1 p.m.
Read Full Article
Novel Vaccine Combo Shows Responses in Recurrent Epithelial Ovarian Cancer - CancerNetwork

Novel Vaccine Combo Shows Responses in Recurrent Epithelial Ovarian Cancer CancerNetwork

Published: Jan. 21, 2026, 4:57 p.m.
Read Full Article
Multi-omics analysis reveals shared diagnostic and therapeutic targets in endometriosis and recurrent implantation failure - Nature

Multi-omics analysis reveals shared diagnostic and therapeutic targets in endometriosis and recurrent implantation failure Nature

Published: Dec. 29, 2025, 6:01 p.m.
Read Full Article
Nab-Sirolimus Plus Letrozole Shows Early Activity in Advanced/Recurrent Endometrioid Endometrial Cancer - OncLive

Nab-Sirolimus Plus Letrozole Shows Early Activity in Advanced/Recurrent Endometrioid Endometrial Cancer OncLive

Published: Dec. 22, 2025, 7:02 p.m.
Read Full Article
The Molecular Classification Ushers in a New Era for the Treatment of Advanced and Recurrent Endometrial Cancer - Frontiers

The Molecular Classification Ushers in a New Era for the Treatment of Advanced and Recurrent Endometrial Cancer Frontiers

Published: Dec. 18, 2025, 3:05 p.m.
Read Full Article
Study Links Endometrial Cell Senescence and Recurrent Spontaneous Abortion to UCP2 and GSR Biomarkers - geneonline.com

Study Links Endometrial Cell Senescence and Recurrent Spontaneous Abortion to UCP2 and GSR Biomarkers geneonline.com

Published: Dec. 12, 2025, 9:41 p.m.
Read Full Article
UCP2 and GSR: Key Biomarkers for Recurrent Abortion - Bioengineer.org

UCP2 and GSR: Key Biomarkers for Recurrent Abortion Bioengineer.org

Published: Dec. 12, 2025, 8:59 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!